z-logo
open-access-imgOpen Access
Retinal Vasculitis Secondary to Durvalumab
Author(s) -
R. Andrade Antonio,
Moll-Udina Aina,
Martin Ruth,
Cilveti Esther,
Subirà Olaia,
Disfetano Laura,
García-Arumí Jose
Publication year - 2020
Publication title -
case reports in ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.299
H-Index - 17
ISSN - 1663-2699
DOI - 10.1159/000507609
Subject(s) - case report
Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, the retinal vasculitis resolved and macular edema improved during follow-up. There was no need for durvalumab to be withdrawn.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here